Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug;49(3):647-659.
doi: 10.1016/j.rdc.2023.03.002. Epub 2023 Mar 17.

Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases

Affiliations
Review

Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases

Magali Noval Rivas et al. Rheum Dis Clin North Am. 2023 Aug.

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a delayed postinflammatory disorder associated with the previous infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Initially, MIS-C was described as highly similar to Kawasaki disease (KD), a pediatric febrile systemic vasculitis that can lead to the development of coronary artery aneurysms (CAAs). While KD and MIS-C are both inflammatory disorders, the 2 entities differ in their epidemiological, clinical, immunological, and pathological features. MIS-C clinical and laboratory characteristics are more closely related to toxic shock syndrome (TSS) than KD, which informs the understanding of pathogenesis and potential therapeutic approaches.

Keywords: Kawasaki disease; Multisystem inflammatory syndrome in children; SARS-CoV-2; Superantigen; Superantigen-like motif; Toxic shock syndrome.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Divergent and overlapping features of KD and MIS-C. (A) Clinical, pathological, and immunological features specific to KD. (B) Clinical, pathological, and immunological features that overlap between KD and MIS-C. (C) Clinical, pathological, and immunological features specific to MIS-C.

Similar articles

Cited by

References

    1. McCrindle B.W., Rowley A.H., Newburger J.W., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–e999. - PubMed
    1. Whittaker E., Bamford A., Kenny J., et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259–269. - PMC - PubMed
    1. Verdoni L., Mazza A., Gervasoni A., et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771–1778. - PMC - PubMed
    1. Cheung E.W., Zachariah P., Gorelik M., et al. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA. 2020;324(3):294–296. - PMC - PubMed
    1. Toubiana J., Poirault C., Corsia A., et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094. - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts